Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Appropriations

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Appropriations ₹13,820 Cr₹11,910 Cr₹9,925 Cr₹8,017 Cr₹6,737 Cr

What is the latest Appropriations of MANKIND PHARMA ?

The latest Appropriations ratio of MANKIND PHARMA is ₹13,820 Cr based on Mar2026 Consolidated results.
Year Appropriations
Mar2026₹13,820 Cr
Mar2025₹11,910 Cr
Mar2024₹9,925 Cr
Mar2023₹8,017 Cr
Mar2022₹6,737 Cr

How is Appropriations of MANKIND PHARMA Trending?

Years Appropriations % Change
Mar2026 ₹13,820 Cr
16.04
Mar2025 ₹11,910 Cr
20.00
Mar2024 ₹9,925 Cr
23.80
Mar2023 ₹8,017 Cr
19.00
Mar2022 ₹6,737 Cr -

Compare Appropriations of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹103,274.8 Cr 9.6% 1% -6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

9.6%

1%

-6.2%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses